Ahmed Haider Wahauib

Title: Ahmed Haider Wahauib: Innovator in Radiolabeled Compounds

Introduction

Ahmed Haider Wahauib is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of radiolabeled compounds. His work is characterized by a focus on cannabinoid receptor ligands, which have important applications in medical research.

Latest Patents

Wahauib holds a patent for a radiolabeled cannabinoid receptor 2 ligand. The present invention relates to a compound of formula (I) wherein R, R, and R are defined as in the description and in the claims. The compound of formula (I) can be used as a radiolabeled ligand, which is crucial for various imaging techniques in medical diagnostics.

Career Highlights

Throughout his career, Wahauib has worked with prominent organizations, including Hoffmann-La Roche Inc. and ETH Zurich. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Simon Mensah Ametamey and Luca Claudio Gobbi. Their collaborative efforts have further advanced the research and development of innovative compounds in the pharmaceutical industry.

Conclusion

Ahmed Haider Wahauib is a distinguished inventor whose work in radiolabeled compounds has the potential to impact medical research significantly. His contributions to the field exemplify the importance of innovation in advancing healthcare solutions.